TYR and melanoma: Notwithstanding all these promising coumarin derivatives found in the literature, herein, we performed an investigation focused on an in-house library of coumarins, aiming to identify potential inhibitors of the tyrosinase enzyme, which could be promising drug candidates against melanoma.